Pages that link to "Q54198251"
Jump to navigation
Jump to search
The following pages link to The effects of cyclosporine on the pharmacokinetics of doxorubicin in patients with small cell lung cancer. (Q54198251):
Displaying 24 items.
- Pharmacokinetic drug-drug interaction and their implication in clinical management (Q27021051) (← links)
- Pharmacological effects of formulation vehicles : implications for cancer chemotherapy (Q33187648) (← links)
- P-glycoprotein and drug therapy in organ transplantation (Q33749785) (← links)
- Pharmacokinetic-pharmacodynamic relationships of the anthracycline anticancer drugs. (Q34696189) (← links)
- High-dose cyclosporin with etoposide--toxicity and pharmacokinetic interaction in children with solid tumours (Q36292923) (← links)
- Use of in vitro and in vivo data to estimate the likelihood of metabolic pharmacokinetic interactions (Q36851934) (← links)
- Cardiomyocyte apoptosis vs autophagy with prolonged doxorubicin treatment: comparison with osteosarcoma cells (Q38957705) (← links)
- Population pharmacokinetics of doxorubicin and doxorubicinol in patients diagnosed with non-Hodgkin's lymphoma (Q39570922) (← links)
- Future perspectives for the development of P-glycoprotein modulators (Q40271710) (← links)
- Antineoplastic agents. Drug interactions of clinical significance. (Q40449518) (← links)
- Interaction of docetaxel ("Taxotere") with human P-glycoprotein (Q40901480) (← links)
- Inhibitory effects of a cyclosporin derivative, SDZ PSC 833, on transport of doxorubicin and vinblastine via human P-glycoprotein (Q40978951) (← links)
- The role of human cytochrome P450 enzymes in the metabolism of anticancer agents: implications for drug interactions (Q41030442) (← links)
- Clinical pharmacokinetics and metabolism of chloroquine. Focus on recent advancements (Q41192707) (← links)
- Clinically significant drug interactions with cyclosporin. An update (Q41201529) (← links)
- Effect of Tamoxifen on the Pharmacokinetics of Doxorubicin in Patients With Non-Hodgkin's Lymphoma (Q42670133) (← links)
- Assessment of the involvement of CYP3A in the vitro metabolism of a new modulator of MDR in cancer chemotherapy, OC144-193, by human liver microsomes (Q43865028) (← links)
- Drug interaction studies between paclitaxel (Taxol) and OC144-093--a new modulator of MDR in cancer chemotherapy (Q44027605) (← links)
- Renal interaction between itraconazole and cimetidine (Q45001575) (← links)
- Potential drug-drug interactions at a referral hematology-oncology ward in Iran: a cross-sectional study. (Q45176557) (← links)
- Model-based optimization of G-CSF treatment during cytotoxic chemotherapy (Q47657705) (← links)
- Approaches to multidrug resistance reversal. (Q53852784) (← links)
- Modifiers of multidrug resistance (Q54166252) (← links)
- Changes in doxorubicin distribution and toxicity in mice pretreated with the cyclosporin analogue SDZ PSC 833. (Q54187619) (← links)